Merck & Co., Inc., known as MSD outside the United States and Canada, is a leading global healthcare company headquartered in Rahway, New Jersey. Founded in 1891, Merck has established itself as a pioneer in the pharmaceutical industry, focusing on innovative medicines, vaccines, and animal health products. With a strong presence in North America, Europe, and emerging markets, Merck is renowned for its commitment to research and development, resulting in groundbreaking therapies in areas such as oncology, infectious diseases, and diabetes management. Notable products include the HPV vaccine Gardasil and the cancer treatment Keytruda, both of which have significantly impacted public health. Merck's dedication to scientific excellence and patient care has solidified its position as a trusted leader in the pharmaceutical sector, consistently achieving recognition for its contributions to global health.
How does Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada's score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merck & Co., Inc., known as MSD outside the US and Canada, is committed to addressing climate change, although specific carbon emissions data for the most recent year is not available. The company has not disclosed any absolute emissions figures in kg CO2e, nor has it set specific reduction targets or initiatives as part of its climate commitments. As of now, there are no emissions data cascaded from a parent or related organization, indicating that Merck operates independently in this regard. The absence of reported emissions and reduction targets suggests that further transparency may be needed to fully understand their environmental impact and commitments. In the context of the pharmaceutical industry, Merck's climate strategy will likely align with broader sector trends towards sustainability and carbon neutrality, but specific details remain unspecified.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
